Paper
0
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
Authors
Published
Jan 3, 2008
Show more
Save
Tip0
TipSave
Abstract
We evaluated capecitabine (an oral fluoropyrimidine) and oxaliplatin (a platinum compound) as alternatives to infused fluorouracil and cisplatin, respectively, for untreated advanced esophagogastric cancer.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.